Real-time enrollment status for this hypoparathyroidism clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 10:07 PM UTC
| NCT Number | NCT07699471 |
| Recruiting Status | Recruiting |
| Condition | Hypoparathyroidism |
| Phase | PHASE3 |
| Target Enrollment | 160 participants |
| Active Locations | 19 sites in the US |
| Sponsor | MBX Biosciences |
| Last Updated on CT.gov | October 13, 2026 (1 week ago) |
As of October 21, 2026: Clinical trial NCT07699471 is currently recruiting participants. This phase3 study for hypoparathyroidism is actively seeking new participants at 19 locations across the United States. The study is sponsored by MBX Biosciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07699471 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 19 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07699471 was last updated 1 week ago (October 13, 2026). HelloStudys verifies this status automatically.